Mitsumasa Fukuda

Dr. Mitsumasa Fukuda

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MFMitsumasa Fukuda
Mitsumasa Fukuda
TMTakeshi Matsuo
Takeshi Matsuo
SFSo Fujimoto
So Fujimoto
HKHirofumi Kashii
Hirofumi Kashii
AHAi Hoshino
Ai Hoshino
SKSatoko Kumada
Satoko Kumada
Vagus nerve stimulation (VNS) is a palliative treatment for drug-resistant epilepsy (DRE) that has been in use for over two decades. VNS suppresses epileptic seizures, prevents emotional disorders, and improves cognitive function and sleep quality, a parallel effect associated with the control of epileptic seizures. The seizure suppression rate with VNS increases monthly to annually, and the incidence of side effects reduces over time. This method is effective in treating DRE in children as well as adults, such as epilepsy associated with tuberous sclerosis, Dravet syndrome, and Lennox–Gastaut syndrome. In children, it has been reported that seizures decreased by >70% approximately 8 years after initiating VNS, and the 50% responder rate was reported to be approximately 70%. VNS regulates stimulation and has multiple useful systems, including self-seizure suppression using magnets, additional stimulation using an automatic seizure detection system, different stimulation settings for day and night, and an automatic stimulation adjustment system that reduces hospital visits. VNS suppresses seizures and has beneficial behavioral effects in children with DRE. This review describes the VNS system, the mechanism of the therapeutic effect, the specific stimulation adjustment method, antiepileptic effects, and other clinical effects in patients with childhood DRE.

1 January 2021 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
AAAtsuko Arisaka
Atsuko Arisaka
MNMitsuko Nakashima
Mitsuko Nakashima
SKSatoko Kumada
Satoko Kumada
KIKenji Inoue
Kenji Inoue
HNHiroya Nishida
Hiroya Nishida
MFMitsumasa Fukuda
Mitsumasa Fukuda
• Epileptic-dyskinetic encephalopathies are rare epileptic disorders characterized by EOEE with involuntary movement. • The presence of involuntary movements in patients with EOEE caused by gene variants may be a key diagnostic symptom. • Genetic diagnosis is useful and may provide a reference for treatment selection.

24 May 2023 in Epileptic Disorders
Verified
Journal Article
Closed access
MFMitsumasa Fukuda
Mitsumasa Fukuda
MTMaya Tojima
Maya Tojima
KIKenji Inoue
Kenji Inoue
HMHideaki Mashimo
Hideaki Mashimo
HKHirofumi Kashii
Hirofumi Kashii
AIAkio Ikeda
Akio Ikeda